FDA Drug Safety Communications
New warnings, restrictions and withdrawals from the US Food and Drug Administration since January 2010, searchable by drug or class.
306 communications, from the FDA's lists, read on 2 November 2026
306 communications, newest first.
- 15 Sept 2026
- 1 Sept 2026
- 10 Jun 2026
- 31 Mar 2026
- 20 Mar 2026
- 13 Jan 2026
- 28 Aug 2025
- 27 Aug 2025
- 31 Jul 2025
- 30 Jun 2025
- 18 Jun 2025
- 16 May 2025
- 22 Jan 2025
- 12 Dec 2024
- 12 Sept 2024
- 19 Jan 2024
- 11 Jan 2024
- 28 Nov 2023FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan)levetiracetamlevetiracetam extended-releaseclobazam
- 11 May 2023
- 13 Apr 2023
- 30 Jun 2022
- 1 Jun 2022
- 30 Mar 2022
- 3 Feb 2022
- 12 Jan 2022
- 2 Nov 2021
- 1 Sept 2021
- 20 Jul 2021
- 16 Jun 2021
- 26 May 2021
- 31 Mar 2021
- 25 Mar 2021
- 4 Feb 2021
- 15 Oct 2020
- 24 Sept 2020
- 23 Sept 2020
- 26 Aug 2020
- 23 Jul 2020
- 24 Apr 2020
- 4 Mar 2020
- 13 Feb 2020
- 28 Jan 2020
- 14 Jan 2020
- 19 Dec 2019FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR)gabapentinpregabalinpregabalin extended-release
- 13 Sept 2019FDA warns about rare but severe lung inflammation with Ibrance, Kisqali, and Verzenio for breast cancerpalbociclibribociclibabemaciclib
- 28 Aug 2019FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver diseaseglecaprevirpibrentasvirelbasvirgrazoprevirsofosbuvirvelpatasvir
- 13 Aug 2019
- 26 Jul 2019
- 30 Apr 2019
- 9 Apr 2019
- 25 Feb 2019
- 21 Feb 2019
- 20 Dec 2018
- 29 Nov 2018
- 29 Nov 2018
- 20 Nov 2018
- 29 Aug 2018
- 2 Aug 2018
- 10 Jul 2018
- 23 May 2018
- 18 May 2018FDA to evaluate potential risk of neural tube birth defects with HIV medicine dolutegravir (Juluca, Tivicay, Triumeq)dolutegravirrilpivirineabacavirlamivudine
- 25 Apr 2018
- 22 Feb 2018
- 1 Feb 2018
- 30 Jan 2018
- 11 Jan 2018
- 20 Dec 2017
- 19 Dec 2017
- 15 Nov 2017
- 21 Sept 2017
- 20 Sept 2017
- 6 Sept 2017
- 22 May 2017
- 16 May 2017
- 27 Apr 2017
- 20 Apr 2017
- 15 Mar 2017
- 2 Feb 2017
- 16 Dec 2016
- 14 Dec 2016
- 12 Dec 2016
- 4 Oct 2016
- 31 Aug 2016
- 26 Jul 2016
- 14 Jun 2016FDA strengthens kidney warnings for diabetes medicines canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR)canagliflozinmetformindapagliflozin
- 7 Jun 2016
- 6 Jun 2016
- 2 Jun 2016
- 19 May 2016
- 18 May 2016
- 12 May 2016
- 10 May 2016
- 3 May 2016FDA warns about new impulse-control problems associated with mental health drug aripiprazole (Abilify, Abilify Maintena, Aristada)aripiprazolearipiprazole lauroxil
- 2 May 2016
- 26 Apr 2016
- 8 Apr 2016
- 5 Apr 2016
- 22 Mar 2016
- 4 Jan 2016
- 16 Dec 2015
- 4 Dec 2015
- 17 Nov 2015
- 6 Nov 2015
- 26 Oct 2015
- 22 Oct 2015
- 22 Oct 2015FDA requires drug interaction studies with potassium-lowering drug Kayexalate (sodium polystyrene sulfonate)sodium polystyrene sulfonate
- 22 Sept 2015
- 21 Sept 2015
- 15 Sept 2015
- 10 Sept 2015
- 28 Aug 2015
- 21 Aug 2015
- 4 Aug 2015
- 30 Jul 2015
- 27 Jul 2015
- 16 Jul 2015
- 9 Jul 2015
- 1 Jul 2015
- 24 Jun 2015
- 16 Jun 2015
- 20 May 2015
- 15 May 2015
- 30 Mar 2015
- 24 Mar 2015
- 23 Mar 2015
- 9 Mar 2015
- 3 Mar 2015
- 25 Feb 2015
- 9 Jan 2015
- 11 Dec 2014
- 25 Nov 2014
- 16 Nov 2014
- 26 Sept 2014
- 26 Jun 2014
- 25 Jun 2014
- 24 Jun 2014
- 20 Jun 2014
- 15 May 2014
- 13 May 2014FDA study of Medicare patients finds lower risk of stroke and death with Pradaxa (dabigatran) compared with warfarindabigatran etexilatedabigatranwarfarin
- 26 Apr 2014
- 23 Apr 2014
- 31 Mar 2014
- 6 Mar 2014
- 11 Feb 2014
- 31 Jan 2014
- 8 Jan 2014
- 20 Dec 2013
- 17 Dec 2013
- 3 Dec 2013
- 25 Nov 2013
- 20 Nov 2013
- 13 Nov 2013
- 6 Nov 2013
- 5 Nov 2013
- 31 Oct 2013
- 11 Oct 2013
- 27 Sept 2013
- 25 Sept 2013
- 23 Sept 2013
- 29 Aug 2013
- 15 Aug 2013
- 1 Aug 2013
- 29 Jul 2013
- 26 Jul 2013
- 3 Jul 2013
- 18 Jun 2013
- 30 May 2013
- 14 May 2013FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CRzolpidemzolpidem extended-release
- 6 May 2013
- 6 May 2013
- 30 Apr 2013
- 14 Mar 2013
- 12 Mar 2013
- 26 Feb 2013
- 20 Feb 2013
- 10 Jan 2013
- 19 Dec 2012
- 19 Dec 2012
- 17 Dec 2012
- 12 Dec 2012
- 6 Dec 2012
- 4 Dec 2012
- 25 Oct 2012
- 13 Sept 2012
- 12 Sept 2012
- 30 Aug 2012
- 23 Jul 2012
- 29 Jun 2012
- 26 Jun 2012
- 14 May 2012
- 7 May 2012
- 26 Apr 2012
- 20 Apr 2012
- 10 Apr 2012
- 28 Mar 2012
- 1 Mar 2012
- 28 Feb 2012
- 15 Feb 2012
- 8 Feb 2012
- 20 Jan 2012
- 13 Jan 2012
- 12 Jan 2012
- 22 Dec 2011
- 20 Dec 2011
- 19 Dec 2011
- 15 Dec 2011
- 14 Dec 2011
- 12 Dec 2011
- 7 Dec 2011
- 6 Dec 2011
- 9 Nov 2011Trilipix - Review update of Trilipix (fenofibric acid) and the ACCORD Lipid Trialfenofibratefenofibric acid
- 4 Nov 2011
- 3 Nov 2011TNF Blockers - UPDATE on Tumor Necrosis Factor (TNF) blockers and risk for pediatric malignancyazathioprinemercaptopurine
- 1 Nov 2011
- 27 Oct 2011
- 25 Oct 2011
- 24 Oct 2011
- 20 Oct 2011
- 20 Oct 2011
- 11 Oct 2011
- 26 Sept 2011
- 15 Sept 2011
- 7 Sept 2011
- 1 Sept 2011
- 1 Sept 2011
- 24 Aug 2011
- 4 Aug 2011
- 4 Aug 2011
- 3 Aug 2011
- 26 Jul 2011
- 26 Jul 2011
- 26 Jul 2011
- 22 Jul 2011
- 21 Jul 2011
- 21 Jul 2011
- 15 Jul 2011
- 11 Jul 2011
- 30 Jun 2011
- 24 Jun 2011
- 16 Jun 2011
- 15 Jun 2011
- 13 Jun 2011
- 9 Jun 2011
- 8 Jun 2011
- 2 Jun 2011
- 31 May 2011
- 18 May 2011
- 6 May 2011
- 22 Apr 2011
- 15 Apr 2011
- 14 Apr 2011
- 14 Apr 2011
- 8 Apr 2011
- 7 Apr 2011
- 7 Apr 2011
- 29 Mar 2011
- 8 Mar 2011
- 4 Mar 2011
- 4 Mar 2011
- 2 Mar 2011
- 1 Mar 2011
- 22 Feb 2011
- 17 Feb 2011
- 3 Feb 2011
- 14 Jan 2011
- 13 Jan 2011
- 12 Jan 2011
- 22 Dec 2010
- 17 Dec 2010
- 14 Dec 2010
- 19 Nov 2010
- 21 Oct 2010
- 20 Oct 2010
- 13 Oct 2010
- 8 Oct 2010
- 17 Sept 2010
- 15 Sept 2010
- 9 Sept 2010
- 1 Sept 2010
- 20 Aug 2010Stalevo - Ongoing Safety Review of Stalevo and possible increased cardiovascular riskcarbidopaentacaponelevodopa
- 12 Aug 2010
- 2 Aug 2010
- 29 Jul 2010
- 29 Jul 2010
- 15 Jul 2010
- 13 Jul 2010
- 8 Jul 2010
- 11 Jun 2010
- 2 Jun 2010
- 26 May 2010
- 25 May 2010
- 12 May 2010
- 3 May 2010
- 21 Apr 2010New Boxed Warning on severe liver injury with propylthiouracilpropylthiouracil
- 7 Apr 2010
- 31 Mar 2010Ongoing Safety Review of Stalevo (entacapone/carbidopa/levodopa) and possible development of Prostate Cancercarbidopaentacaponelevodopa
- 19 Mar 2010
- 12 Mar 2010
- 10 Mar 2010
- 26 Feb 2010Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranespepoetin alfadarbepoetin alfa
- 23 Feb 2010
- 22 Feb 2010
- 18 Feb 2010
- 17 Feb 2010
- 5 Feb 2010
- 29 Jan 2010
Source: FDA Drug Safety Communications, a US government work. Each title links to the FDA's page, or for those before 2020 to its archived copy. Ayulex shows a communication under any answer that recommends a drug or class it concerns. All sources